Julie Vermeers
Medical · la Jolla, CANPI 1245272079
Payments from drug & device makers
Across 84 payments — averaging $26.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$386
- EDAP Technomed Inc$379
- Sumitomo Pharma America, Inc.$237
- Immunitybio, Inc.$190
- ABC Home Medical Supply, Inc.$116
- Coloplast$98
- plus $795 from 16 others
What the payments were for
- Food & beverage$2,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $386 |
| EDAP Technomed Inc | 4 | $379 |
| Sumitomo Pharma America, Inc. | 11 | $237 |
| Immunitybio, Inc. | 8 | $190 |
| ABC Home Medical Supply, Inc. | 5 | $116 |
| Coloplast | 4 | $98 |
| Johnson & Johnson | 5 | $96 |
| Boston Scientific | 3 | $94 |
| Urovant Sciences Inc | 4 | $83 |
| Pfizer | 4 | $76 |
| Medtronic | 2 | $62 |
| Urogen Pharma, Inc. | 2 | $59 |
| Convatec Inc. | 2 | $50 |
| Accord Healthcare, Inc. | 2 | $49 |
| Endo Pharmaceuticals Inc. | 2 | $48 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| 180 Medical, Inc. | 1 | $25 |
| Axonics, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $21 |
| Bayer | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
How this compares
$2,201 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $6,483 |
| Tamsulosin Hcl | 188 | $2,212 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $538 |
| Finasteride | 44 | $471 |
| CefuroximeCefuroxime Axetil | 19 | $350 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $224 |
| Ciprofloxacin Hcl | 41 | $178 |
| Oxybutynin Chloride | 43 | $139 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $53 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $50 |
| Fluconazole | 20 | $48 |
Paid to pharmacies, not to this prescriber.
Other medical in la Jolla
- Nicole Romeola Jolla$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.